TELA Bio (TELA) Gross Margin (2018 - 2026)

TELA Bio's Gross Margin history runs 9 years deep, the most recent figure standing at 65.69% for Q1 2026.

• In Q1 2026, Gross Margin fell 187.0% year-over-year to 65.69%; the TTM figure through Mar 2026 stood at 67.25% (up 32.0% YoY), while the FY2025 annual figure was 67.69%, up 61.0% from the prior year.
• Gross Margin was 65.69% for Q1 2026 at TELA Bio, roughly flat from 65.91% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 70.38% in Q2 2023 to a low of 60.73% in Q1 2022.
• Historically, Gross Margin has averaged 66.98% across 5 years, with a median of 67.56% in 2025.
• The sharpest annual moves came in 2023 and 2024: Gross Margin jumped 744 bps in 2023, then sank 481 bps in 2024.
• A 5-year view of Gross Margin shows it stood at 70.35% in 2022, then decreased by 3 bps to 68.38% in 2023, then dropped by 7 bps to 63.58% in 2024, then grew by 4 bps to 65.91% in 2025, then fell by 0 bps to 65.69% in 2026.
• The last three Gross Margin figures came in at 65.69% (Q1 2026), 65.91% (Q4 2025), and 67.52% (Q3 2025), per Business Quant data.